《Journal Of The American Academy Of Dermatology》重点专注发布医学-皮肤病学领域的新研究，旨在促进和传播该领域相关的新技术和新知识。鼓励该领域研究者详细地发表他们的高质量实验研究和理论结果。根据网友分享的投稿经验，平均审稿速度为 一般,3-6周 约7.6周。该杂志创刊至今，在医学-皮肤病学领域，影响力非凡，对来稿文章质量要求很高，稿件投稿过审难度很大，刊登文章的学术水平和编辑质量在同类杂志中均名列前茅。如果你想在该杂志上发表论文，你可以向编辑部提交文章，但文章必须具有重要意义并代表该领域专业的发展。我们欢迎广大同领域的研究者提交投稿。
| CiteScore | SJR | SNIP | CiteScore排名 | |||
|---|---|---|---|---|---|---|
| 8.6 | 1.677 | 1.712 | 学科类别 | 分区 | 排名 | 百分位 |
|
大类：大类：Medicine
小类：小类：Dermatology
|
Q1 | 8/142 | 94% | |||
| 按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：DERMATOLOGY | SCIE | Q1 | 1 / 94 | 99.5% |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
|---|---|---|---|---|
| 学科：DERMATOLOGY | SCIE | Q1 | 2 / 94 | 98.4% |
文章名称
引用次数
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
102
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
62
Guidelines of care for the management of primary cutaneous melanoma
57
Psoriasis: Which therapy for which patient Psoriasis comorbidities and preferred systemic agents
57
Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee
55
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
55
Cutaneous squamous cell carcinoma Incidence, risk factors, diagnosis, and staging
55
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
50
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics
48
Psoriasis: Which therapy for which patient Focus on special populations and chronic infections
48
国家/地区
发文量
TUSA
3612
TCanada
366
TSpain
308
TFrance
232
TGERMANY (FED REP GER)
229
TEngland
213
TSouth Korea
188
TAustralia
165
TIndia
160
TItaly
143
